Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study

por Fietz, Thomas, Zahn, Mark-Oliver, Köhler, Andreas, Engel, Erik, Frank, Melanie, Kruggel, Lisa, Jänicke, Martina, Marschner, Norbert
Publicado 2017

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastat...

por Marschner, Norbert, Arnold, Dirk, Engel, Erik, Hutzschenreuter, Ulrich, Rauh, Jacqueline, Freier, Werner, Hartmann, Holger, Frank, Melanie, Jänicke, Martina
Publicado 2015

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer

por Dellas, Kathrin, Höhler, Thomas, Reese, Thomas, Würschmidt, Florian, Engel, Erik, Rödel, Claus, Wagner, Wolfgang, Richter, Michael, Arnold, Dirk, Dunst, Jürgen
Publicado 2013

Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer

por Braig, Friederike, März, Manuela, Schieferdecker, Aneta, Schulte, Alexander, Voigt, Mareike, Stein, Alexander, Grob, Tobias, Alawi, Malik, Indenbirken, Daniela, Kriegs, Malte, Engel, Erik, Vanhoefer, Udo, Grundhoff, Adam, Loges, Sonja, Riecken, Kristoffer, Fehse, Boris, Bokemeyer, Carsten, Binder, Mascha
Publicado 2015